PIK3CA and colonic neoplasm: In particular, the PI3K/mTOR pathway was shown to be one of the mechanisms underlying the resistance of BRAFV600E colon cancer cells to BRAF inhibition that could be overcome by concurrent BRAF and PI3K/mTOR blockade [12].